JOINN Clinical (Suzhou) Co., Ltd. and Tonghua Central Hospital jointly built Phase I Clinical Research Center
2018-07-10
November 7, 2018, Zhihou Wang, Secretary of the Communist Party of China of Tonghua City, Huawen Liu, Deputy Secretary of the Communist Party of China and Mayor of Tonghua City, Guochang Wang, Deputy Mayor of Tonghua City, Fengsheng Che, Chairman of the Board of Hainan Sihuan Pharmaceutical Co., Ltd., Conglin Zuo, General Manager of JOINN Laboratories (China) Co., Ltd., and Chairman of JOINN Clinical Trials (Suzhou) Co., Ltd., Tiejun Cao, General Manager of Beijing Stem Technology Co., Ltd, Hong Wang, Deputy Secretary-General of Tonghua Municipal Party Committee, and Shudong Wang, President of Tonghua Central Hospital, Tonghua Municipal Commission of Health and Family Planning, Food and Drug Administration attended the symposium and signing ceremony of clinical trial center and clinical biological sample analysis.
Signing Ceremony
Zhihou Wang, on behalf of the municipal party committee and secretary of municipal party committee of municipal government, congratulates on signing the cooperation project. It also fills in the gaps in clinical trials and drug analysis in the development of the whole industrial chain of Tonghua Biomedical, and keep deepen cooperation and strive for more fruitful results.
At the end of the symposium, Vice Mayor Guochang Wang presided over the signing ceremony. Tonghua Central Hospital and JOINN Clinical Trials (Suzhou) Co., Ltd., Tonghua Central Inspection Analysis and Testing Service Co., Ltd., JOINN Laboratories (China) Co., Ltd., Beijing Stem Technology Co., Ltd. Contract was made on the joint construction of phase Ⅰ clinical trial center and clinical biological sample analysis technology project respectively. The successful signing of this contract will provide high quality and more convenient clinical trial sites for pharmaceutical enterprises in the "Pharmaceutical City", and further improve the scientific research level of the Central Hospital of Tonghua City.
